US Stock MarketDetailed Quotes
ABEO Abeona Therapeutics
- 4.1400
- +0.7000+20.35%
Close Apr 30 16:00 ET
- 4.1700
- +0.0300+0.72%
Post 19:59 ET
113.25MMarket Cap-1636P/E (TTM)
4.2100High3.4400Low2.23MVolume3.4600Open3.4400Pre Close8.88MTurnover11.69%Turnover RatioLossP/E (Static)27.36MShares9.010052wk High7.64P/B78.93MFloat Cap2.830052wk Low--Dividend TTM19.07MShs Float171874.8797Historical High--Div YieldTTM22.38%Amplitude2.1900Historical Low3.9840Avg Price1Lot Size
Abeona Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 14.89%-37.01M | 34.00%-9.24M | 15.39%-5.75M | -14.10%-10.28M | 14.20%-11.74M | 33.78%-43.48M | 53.76%-13.99M | 34.28%-6.79M | 21.55%-9.01M | -0.75%-13.69M |
| Net income from continuing operations | -36.51%-54.19M | -132.99%-16.59M | -83.96%-11.84M | -306.49%-16.65M | 58.69%-9.11M | 53.26%-39.7M | 84.75%-7.12M | 8.66%-6.43M | 73.06%-4.1M | -37.76%-22.04M |
| Operating gains losses | 218.29%10.68M | 189.65%4.23M | 136.44%1.11M | 400.71%7.61M | -280.77%-2.27M | -413.42%-9.03M | ---4.71M | ---3.04M | ---2.53M | --1.25M |
| Depreciation and amortization | -30.13%3.2M | -28.54%721K | -30.78%751K | -38.83%838K | -20.22%888K | 2.53%4.58M | -15.64%1.01M | 0.09%1.09M | 24.66%1.37M | 2.58%1.11M |
| Other non cash items | -8.99%324K | 93.34%-119K | 146.46%313K | 110.88%147K | -100.50%-17K | 105.43%356K | -2,568.66%-1.79M | 101.88%127K | -1,058.16%-1.35M | 2,594.40%3.37M |
| Change In working capital | 69.65%-1.79M | 125.35%1.02M | 183.33%2.36M | -101.21%-3.15M | -74.29%-2.01M | 67.74%-5.89M | 79.11%-4M | -47.88%834K | -3,234.00%-1.57M | -55.45%-1.16M |
| -Change in receivables | -172.58%-2.04M | -102.33%-20K | 97.64%3.52M | -93.28%-5.46M | -102.50%-75K | 193.73%2.81M | 128.63%859K | --1.78M | ---2.83M | --3M |
| -Change in prepaid assets | -107.94%-155K | -26.30%384K | -51.92%238K | -24.37%422K | -416.36%-1.2M | 490.03%1.95M | 135.44%521K | 19.57%495K | 10.50%558K | -57.03%379K |
| -Change in payables and accrued expense | 122.41%2.04M | 154.81%2.18M | -18.43%-1.36M | 170.37%1.9M | 85.39%-684K | 41.57%-9.11M | 72.93%-3.98M | -196.46%-1.15M | 254.97%702K | -191.71%-4.68M |
| -Change in other current assets | -287.20%-234K | -500.00%-138K | ---31K | ---9K | -137.84%-56K | 1,885.71%125K | -243.75%-23K | --0 | --0 | 840.00%148K |
| -Change in other current liabilities | 16.43%-1.4M | -1.16%-1.39M | 97.97%-6K | --0 | --1K | ---1.67M | ---1.38M | ---296K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 14.89%-37.01M | 34.00%-9.24M | 15.39%-5.75M | -14.10%-10.28M | 14.20%-11.74M | 33.78%-43.48M | 53.76%-13.99M | 34.28%-6.79M | 21.55%-9.01M | -0.75%-13.69M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 100.87%208K | 145.59%11.53M | -1,236.63%-18.74M | 472.75%5.21M | 105.67%2.21M | -136.28%-23.96M | -416.16%-25.29M | -93.84%1.65M | -106.38%-1.4M | -88.53%1.08M |
| Capital expenditure reported | -154.62%-331K | -48.00%-37K | -2,100.00%-44K | ---32K | -111.65%-218K | 96.87%-130K | 99.23%-25K | 99.50%-2K | --0 | 76.80%-103K |
| Net PPE purchase and sale | -88.24%204K | -88.19%17K | -92.23%8K | ---- | ---- | --1.73M | --144K | --103K | ---- | ---- |
| Net investment purchase and sale | 101.31%335K | 145.45%11.55M | -1,308.46%-18.71M | 275.53%5.06M | 106.20%2.43M | -136.41%-25.57M | -325.92%-25.41M | -94.30%1.55M | -113.12%-2.89M | -88.00%1.18M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 100.87%208K | 145.59%11.53M | -1,236.63%-18.74M | 472.75%5.21M | 105.67%2.21M | -136.28%-23.96M | -416.16%-25.29M | -93.84%1.65M | -106.38%-1.4M | -88.53%1.08M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -14.17%37.06M | -82.54%7.47M | 448.48%22.98M | 274.99%6.62M | -4K | 73.66%43.17M | 161.87%42.77M | 2,321.39%4.19M | -252.56%-3.78M | 0 |
| Net common stock issuance | -20.38%37.39M | -81.80%7.79M | 448.58%22.98M | --6.63M | ---4K | 95.42%46.96M | 161.90%42.77M | 12,593.94%4.19M | --0 | --0 |
| Net preferred stock issuance | --0 | --0 | --0 | ---- | ---- | ---3.78M | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | -3,540.00%-182K | -3,280.00%-169K | ---- | ---- | ---- | -100.60%-5K | ---5K | ---- | ---- | ---- |
| Net other financing activities | ---150K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -14.17%37.06M | -82.54%7.47M | 448.48%22.98M | 274.99%6.62M | ---4K | 73.66%43.17M | 161.87%42.77M | 2,321.39%4.19M | -252.56%-3.78M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -62.52%14.56M | -54.39%5.05M | -45.42%6.56M | -80.86%5.02M | -62.52%14.56M | 186.12%38.83M | -75.26%11.07M | -57.29%12.02M | 72.03%26.22M | 186.12%38.83M |
| Current changes in cash | 101.05%256K | 180.17%9.76M | -58.76%-1.51M | 110.89%1.55M | 24.38%-9.54M | -196.10%-24.27M | 158.78%3.48M | -105.74%-953K | -209.90%-14.19M | -855.66%-12.61M |
| End cash Position | 1.76%14.81M | 1.76%14.81M | -54.39%5.05M | -45.42%6.56M | -80.86%5.02M | -62.52%14.56M | -62.52%14.56M | -75.26%11.07M | -57.29%12.02M | 72.03%26.22M |
| Free cash flow | 14.38%-37.34M | 33.85%-9.27M | 14.77%-5.79M | -14.46%-10.32M | 13.26%-11.96M | 37.53%-43.61M | 58.16%-14.02M | 36.73%-6.79M | 21.94%-9.01M | 1.70%-13.79M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg